The Use of Oral Amino‐Bisphosphonates and Coronavirus Disease 2019 (COVID‐19) Outcomes

The determinants of the susceptibility to severe acute respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2) infection and severe coronavirus disease 2019 (COVID‐19) manifestations are yet not fully understood. Amino‐bisphosphonates (N‐BPs) have anti‐inflammatory properties and have been shown to reduce t...

Descripción completa

Detalles Bibliográficos
Autores principales: Degli Esposti, Luca, Perrone, Valentina, Sangiorgi, Diego, Andretta, Margherita, Bartolini, Fausto, Cavaliere, Arturo, Ciaccia, Andrea, Dell'orco, Stefania, Grego, Stefano, Salzano, Sara, Ubertazzo, Loredana, Vercellone, Adriano, Gatti, Davide, Fassio, Angelo, Viapiana, Ombretta, Rossini, Maurizio, Adami, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420492/
https://www.ncbi.nlm.nih.gov/pubmed/34405441
http://dx.doi.org/10.1002/jbmr.4419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420492/
https://www.ncbi.nlm.nih.gov/pubmed/34405441
http://dx.doi.org/10.1002/jbmr.4419

Ejemplares similares